ATE209500T1 - Ein neuartiges, antineoplastisches cytokin - Google Patents

Ein neuartiges, antineoplastisches cytokin

Info

Publication number
ATE209500T1
ATE209500T1 AT93910750T AT93910750T ATE209500T1 AT E209500 T1 ATE209500 T1 AT E209500T1 AT 93910750 T AT93910750 T AT 93910750T AT 93910750 T AT93910750 T AT 93910750T AT E209500 T1 ATE209500 T1 AT E209500T1
Authority
AT
Austria
Prior art keywords
oncoinhibin
human
cytokine
provides
novel antineoplastic
Prior art date
Application number
AT93910750T
Other languages
English (en)
Inventor
Bharat Aggarwal
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Application granted granted Critical
Publication of ATE209500T1 publication Critical patent/ATE209500T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93910750T 1992-04-24 1993-04-23 Ein neuartiges, antineoplastisches cytokin ATE209500T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/874,308 US5241051A (en) 1992-04-24 1992-04-24 Oncoinhibin
PCT/US1993/003828 WO1993022346A1 (en) 1992-04-24 1993-04-23 A novel anti-neoplastic cytokine

Publications (1)

Publication Number Publication Date
ATE209500T1 true ATE209500T1 (de) 2001-12-15

Family

ID=25363462

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93910750T ATE209500T1 (de) 1992-04-24 1993-04-23 Ein neuartiges, antineoplastisches cytokin

Country Status (18)

Country Link
US (1) US5241051A (de)
EP (1) EP0637319B1 (de)
JP (1) JP3434511B2 (de)
KR (1) KR950701347A (de)
CN (1) CN1068335C (de)
AT (1) ATE209500T1 (de)
AU (1) AU671637B2 (de)
CA (1) CA2118498C (de)
DE (1) DE69331231T2 (de)
FI (1) FI112081B (de)
IL (1) IL105473A (de)
NO (1) NO313099B1 (de)
NZ (1) NZ252429A (de)
RU (1) RU2139087C1 (de)
SA (1) SA93140393B1 (de)
TW (1) TW372873B (de)
WO (1) WO1993022346A1 (de)
ZA (1) ZA932830B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993798A (en) * 1992-04-24 1999-11-30 Research Development Foundation Oncoinhibin and methods of pharmaceutical use
DK0914043T3 (da) * 1996-04-03 2004-02-09 Rogosin Inst Implanterbare agarose-kollagen-korn, som indeholder celler, der dannet et diffunderbart produkt, og anvendelser heraf
RU2136695C1 (ru) * 1998-03-18 1999-09-10 ЗАОПП "Эндо-Фарм-А" Сывороточный гликопротеин, обладающий биологической активностью в сверхмалых дозах
BR112014017650B1 (pt) * 2012-01-18 2023-05-02 Biosuccess Biotech Co. Ltd Uso de ésteres de forbol para tratar ou prevenir um ou mais dos sintomas da doença de parkinson
US11136405B2 (en) * 2016-06-06 2021-10-05 Board Of Regents, The Unviersity Of Texas System BAFF-R antibodies and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6463395A (en) * 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
US4874746A (en) * 1987-12-22 1989-10-17 Institute Of Molecular Biology, Inc. Wound headling composition of TGF-alpha and PDGF
US4868902A (en) * 1988-02-03 1989-09-19 Hughes Aircraft Company GaAs capacitive feedback transimpedance amplifier
DE69032816T2 (de) * 1989-04-10 1999-07-29 Oncogen Ltd. Partnership, Seattle, Wash. Verwendung von oncostatin m zur suppression von mhc antigenen

Also Published As

Publication number Publication date
AU4113593A (en) 1993-11-29
RU2139087C1 (ru) 1999-10-10
SA93140393B1 (ar) 2006-05-23
TW372873B (en) 1999-11-01
EP0637319B1 (de) 2001-11-28
EP0637319A4 (de) 1997-06-11
AU671637B2 (en) 1996-09-05
KR950701347A (ko) 1995-03-23
CA2118498A1 (en) 1993-11-11
JP3434511B2 (ja) 2003-08-11
NO943968L (no) 1994-10-19
CN1083389A (zh) 1994-03-09
FI944907A0 (fi) 1994-10-19
EP0637319A1 (de) 1995-02-08
NO313099B1 (no) 2002-08-12
IL105473A (en) 1998-09-24
IL105473A0 (en) 1993-08-18
FI944907L (fi) 1994-10-19
JPH07506364A (ja) 1995-07-13
NO943968D0 (no) 1994-10-19
RU94045922A (ru) 1997-05-10
CN1068335C (zh) 2001-07-11
DE69331231D1 (de) 2002-01-10
CA2118498C (en) 2005-06-21
US5241051A (en) 1993-08-31
FI112081B (fi) 2003-10-31
DE69331231T2 (de) 2002-08-22
NZ252429A (en) 1996-06-25
ZA932830B (en) 1994-11-22
WO1993022346A1 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
IT8920207A0 (it) Procedimento per la preparazione di perfluoropolieteri perossidici.
BR9004922A (pt) Protese de valvula cardiaca
IT8722481A0 (it) Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse.
DE58908155D1 (de) Endoprothese des hüftgelenks.
IT1231549B (it) Procedimento per la produzione di semilavorati di cuoio
IT1229144B (it) Procedimento per la produzione di carbammati.
ES1011643Y (es) Mesa elevadora para correccion de la pelvis..
IT8667628A1 (it) Procedimento per la fabbricazione di strutture dicroiche d'antenna.
IT1230068B (it) Procedimento per la preparazione di n sulfoniluree.
DE69331231D1 (de) Ein neuartiges, antineoplastisches cytokin
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
CS326486A2 (en) Method of 17-alpha-phenyl-17-beta-hydroxy-18-methyl-4,15-oestradien-3-on' production
IT9067657A0 (it) Procedimento per la preparazione di alfa-alchil-lattoni.
DK0579939T3 (da) Phospholipidderivater
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
IT8921657A0 (it) Procedimento per la produzione di cuoio morbido senza piombo.
DK189285D0 (da) (6,11-dihydro-11-oxodibenz(b,e)oxepinyl)-pentancarboxylsyrer, deres fremstilling og anvendelse
IT9067138A1 (it) Procedimento per la preparazione di alfa-alchil lattoni.
ES542554A0 (es) Un procedimiento para preparar (6,11-dihidro-11-oxodibenznb,e)oxepinil)pentanoles
FI931938A7 (fi) Välituotteita 4,5-difluoriantraniliinihapon valmistuksessa
IT1230745B (it) Procedimento per la preparazione di n fosfonometilglicina.
IT8920041A0 (it) Procedimento per la produzione di isocianati.
IT8919405A0 (it) Procedimento per la preparazione di pentaclorotiofenolo.
ES1010441Y (es) Mesa para la practica de lucha de brazos.
FI925819A7 (fi) Menetelmä terapeuttisesti aktiivisen 11H-dibentso/b,e//1,4/diatsepin-11-onien valmistamiseksi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties